1-Testosterone
1-Testosterone (Dihydroboldenone/DHB) is the 5-alpha-reduced form of Boldenone, making it essentially the dry DHT-like version of Equipoise. It provides a non-aromatizing injectable anabolic signal with hardness, strength, and recomposition potential.
DHB sits between Equipoise, Primo, and Trenbolone in practical discussion: stronger and drier than EQ, more potent than Primo for many users, but less psychologically disruptive than Tren. Severe post-injection pain is the main limiter.
DHB is chosen by users who want a stronger dry injectable than Primobolan or Masteron without moving into tren. It fits cutting and recomp phases where estrogen control needs to stay simple and water retention would hide the result.
DHB also suits users who like EQ’s endurance and vascularity but do not want EQ’s long detection window, appetite push, or confusing estradiol behavior. The trade is straightforward: dry anabolic output, strength, hardness, and less hormonal noise.
Administration: Injectable compound. Most users split into 2 injections per week to keep blood levels steadier and side effects easier to read.
Ester handling: Available as Cypionate. Short esters usually need more frequent injections, while longer esters trade flexibility for convenience.
Support planning: Build the rest of the cycle around the actual downside profile of this compound, not just the look or strength result it promises.
Stop or reduce if: blood pressure climbs, sleep degrades, libido crashes, or labs move sharply in the wrong direction.
Most DHB is cypionate, so it does not fully declare itself in the first few days. Strength, vascularity, and body-composition changes usually become easier to judge after weeks 3-5. It works best when given enough time to accumulate, but the injection tolerability has to be solved early.
Common use clusters around 300-500mg/week. Higher dosing is often limited by injection-site inflammation before systemic side effects become the main issue. Splitting injections and avoiding high-concentration preparations can make the difference between a usable cycle and a miserable one.
1-Testosterone, better known as DHB or dihydroboldenone, is the 5-alpha-reduced form of Equipoise. It keeps some of EQ’s lean-gain and vascularity character, but removes aromatization and produces a harder, drier result. It is not testosterone despite the name, and it does not behave like a simple testosterone replacement.
DHB is used when someone wants a potent non-aromatizing injectable that can drive recomposition, strength, and muscle density without the mental volatility of Trenbolone or the joint-dry oral feel of Winstrol. The look is dense and dry rather than wet or scale-heavy.
Post-injection pain is the limiting factor. DHB can be brutally irritating depending on concentration, carrier, solvent load, and individual response. Bad DHB can create hard knots, swelling, flu-like inflammation, and missed training days. That one issue decides whether the compound is usable for many people.
The biggest mistake is buying a high-concentration DHB product and treating severe injection pain as acceptable. If every shot causes swelling and systemic inflammation, training quality suffers and the cycle becomes self-defeating.
Another mistake is comparing it to tren because both can recomp. DHB does not have tren’s nutrient-partitioning intensity or psychological profile. It is better understood as a stronger, drier, more difficult-to-inject cousin of EQ and primo.
Compared with Equipoise, DHB is drier, harder, and does not aromatize, but it loses some of EQ’s smoother long-run feel and is much more injection-site dependent.
Compared with Primo, DHB is usually more potent per milligram and more visually aggressive. Primo is easier to tolerate and better for long cycles where injection comfort, lipids, and predictability matter more than acute visual change.
Compared with Trenbolone, DHB is less dramatic but much easier mentally for many users. Tren is the stronger recomp drug. DHB is the cleaner dry anabolic if the injection pain can be managed.
Natural suppression with reduced fertility and testicular output
Acne, oily skin, scalp hair loss, and prostate irritation in susceptible users
CBC / hematocrit
blood pressure
lipid panel
PSA if age or symptoms justify it
Uncontrolled hypertension or untreated cardiovascular disease
Pre-existing severe infertility concerns unless that risk is accepted and managed
Aggressive hair loss history or significant prostate symptoms
First-cycle or low-experience use